SPM Corp operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares SPM Corp with three other
drug stores in Asia:
Seouleaguer Co Ltd
of South Korea
sales of 17.51 billion Korean Won [US$14.85 million]
of which 57%
was Health care Segment),
TCM Biotech International Corp
(540.23 million Taiwanese Dollars [US$18.01 million]
Lam Dong Pharmaceutical JSC
(431.85 billion Dong [US$18.57 million]
SPM Corp reported sales of 390.72 billion Dong (US$16.80 million)
December of 2018.
decrease of 38.6%
versus 2017, when the company's sales were 636.02 billion Dong.
Contributing to the drop in overall sales was the 99.4% decline
in Real Estate, from 276.75 billion Dong to 1.75 billion Dong.
There were also decreases in sales in
Pharmacy (down 3.9% to 232.19 billion Dong)
However, these declines were partially offset by the increase in sales of
Pharmacy Trading (up 33.1% to 156.79 billion Dong)